{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:16:55Z","timestamp":1781842615722,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.radcr.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T19:50:10Z","timestamp":1687377010000},"page":"3037-3040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-2300","authenticated-orcid":false,"given":"Yasuhito","family":"Mitsuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-9789","authenticated-orcid":false,"given":"Ken","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Shinkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-4790","authenticated-orcid":false,"given":"Atsushi","family":"Jogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-4740","authenticated-orcid":false,"given":"Etsuji","family":"Sohgawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5221-7258","authenticated-orcid":false,"given":"Shigekazu","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-6973","authenticated-orcid":false,"given":"Takeaki","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.radcr.2023.06.012_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.radcr.2023.06.012_bib0002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Raoul JL, et\u00a0al. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.radcr.2023.06.012_bib0003","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000510911","article-title":"Lenvatinib-induced tumor-related hemorrhages in patients with large hepatocellular carcinomas","volume":"99","author":"Uchida-Kobayashi","year":"2021","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.radcr.2023.06.012_bib0004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.14309\/ajg.0000000000000747","article-title":"Lenvatinib-induced tumor-related hemorrhage in patients with unresectable hepatocellular carcinoma","volume":"116","author":"Kotani","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"10.1016\/j.radcr.2023.06.012_bib0005","article-title":"Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab","volume":"29","author":"Hsu","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"10.1016\/j.radcr.2023.06.012_bib0006","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.EJ17-0104","article-title":"Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma","volume":"64","author":"Masaki","year":"2017","journal-title":"Endocr J"},{"issue":"7","key":"10.1016\/j.radcr.2023.06.012_bib0007","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.21873\/anticanres.13537","article-title":"Yano S. Clinical characteristics associated with lenvatinib-induced fistula and tumor-related bleeding in patients with thyroid cancer","volume":"39","author":"Staub","year":"2019","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.radcr.2023.06.012_bib0008","first-page":"1393","article-title":"Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer","volume":"7","author":"Ono","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"6","key":"10.1016\/j.radcr.2023.06.012_bib0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1752-1947-6-188","article-title":"Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report","volume":"9","author":"Uysal","year":"2012","journal-title":"J Med Case Rep"},{"issue":"10","key":"10.1016\/j.radcr.2023.06.012_bib0010","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00270-020-02501-w","article-title":"Occurrence of vascular lake phenomenon before embolization for the prediction of lipiodol uptake for intermediate-stage hepatocellular carcinoma patients that underwent cTACE","volume":"43","author":"Hu","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"12","key":"10.1016\/j.radcr.2023.06.012_bib0011","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11604-015-0486-2","article-title":"Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres","volume":"33","author":"Seki","year":"2015","journal-title":"Jpn J Radiol"},{"issue":"7","key":"10.1016\/j.radcr.2023.06.012_bib0012","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00270-017-1678-1","article-title":"Occurrence of vascular lake phenomenon as a predictor of improved tumor response in HCC patients that underwent DEB-TACE","volume":"40","author":"Cavalcante","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"22","key":"10.1016\/j.radcr.2023.06.012_bib0013","doi-asserted-by":"crossref","first-page":"e10945","DOI":"10.1097\/MD.0000000000010945","article-title":"Hepatocellular carcinoma with thoracic metastases presenting as hemothorax: a case report and literature review","volume":"97","author":"Yen","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.radcr.2023.06.012_bib0014","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2169\/internalmedicine.6003-20","article-title":"Successful transcatheter arterial embolization for hemothorax from a spontaneous rupture of hepatocellular carcinoma metastasis to the chest wall in an elderly patient","volume":"60","author":"Suoh","year":"2021","journal-title":"Intern Med"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043323003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043323003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:04:41Z","timestamp":1761825881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043323003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1930043323003849"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2023.06.012","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}